Sensus Healthcare Inc
For the period ended Jun 30, 2024. Filed Aug 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 13, 2024
SRTS$3.30+3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Common Stock · Additional Paid-In · Treasury Stock · Retained | |||||||
|---|---|---|---|---|---|---|---|
| (in thousands, except shares) | Shares | Amount | Capital | Shares | Amount | Earnings | Total |
| December 31, 2022 | 16,902,761 | $169 | $45,031 | (512,342) | $(3,433) | $6,302 | $48,069 |
| Stock-based compensation | 10,000 | - | 161 | - | - | - | 161 |
| Exercise of stock options | 8,334 | - | 46 | - | - | - | 46 |
| Forfeiture of restricted stock units | (7,500) | - | (18) | - | - | - | (18) |
| Surrender of shares for tax withholding on stock-based compensation | - | - | - | (4,487) | (40) | - | (40) |
| Net loss | - | - | - | - | - | (1,894) | (1,894) |
| March 31, 2023 | 16,913,595 | $169 | $45,220 | (516,829) | $(3,473) | $4,408 | $46,324 |
| Stock-based compensation | - | - | 67 | - | - | - | 67 |
| Forfeiture of restricted stock units | (1,000) | - | (1) | - | - | - | (1) |
| Net loss | - | - | - | - | - | (380) | (380) |
| June 30, 2023 | 16,912,595 | $169 | $45,286 | (516,829) | $(3,473) | $4,028 | $46,010 |
| December 31, 2023 | 16,907,095 | $169 | $45,405 | (532,924) | $(3,519) | $6,787 | $48,842 |
| Stock-based compensation | 20,000 | - | 92 | - | - | - | 92 |
| Forfeiture of restricted stock units | (1,500) | - | (1) | - | - | - | (1) |
| Net income | - | - | - | - | - | 2,274 | 2,274 |
| March 31, 2024 | 16,925,595 | $169 | $45,496 | (532,924) | $(3,519) | $9,061 | $51,207 |
| Stock-based compensation | - | - | 66 | - | - | - | 66 |
| Exercise of stock options | 3,000 | - | 17 | - | - | - | 17 |
| Forfeiture of restricted stock units | (750) | - | (1) | - | - | - | (1) |
| Net income | - | - | - | - | - | 1,612 | 1,612 |
| June 30, 2024 | 16,927,845 | $169 | $45,578 | (532,924) | $(3,519) | $10,673 | $52,901 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.